Finland introduces a new care pathway for epilepsy
en-GBde-DEes-ESfr-FR

Finland introduces a new care pathway for epilepsy


The Finnish epilepsy care pathway has been published in Epilepsia Open. This Finnish model for epilepsy care provides a streamlined, multidisciplinary approach to the diagnosis and treatment of epilepsy, and combines modern digital tools, data sharing and peer support. The Finnish epilepsy care pathway can serve to model how integrated healthcare systems can effectively manage complex conditions.

“The Finnish model could serve as a template for other healthcare systems looking for a benchmark to improve their epilepsy care,” says Professor Reetta Kälviäinen of the University of Eastern Finland, who chaired the national work group.

Integrated care pathways are essential for consistent, effective epilepsy care, offering equal access and quality regardless of socioeconomic status. They must align with the WHO Global Action Plan on Epilepsy and other Neurological Diseases, ensuring best practices and cost-effective management. The Finnish national epilepsy care pathway includes multiple levels of care, from initial diagnosis to long-term care for all types of epilepsy, with a specific focus on rare and complex cases integrated with the European Reference Network (ERN) for Rare and Complex Epilepsies, ERN EpiCARE.

In 2017, the Finnish government nominated Kuopio University Hospital to coordinate diagnostics and care for severe epilepsy in Finland. A national multidisciplinary consensus panel, including specialists from both adult and paediatric neurology departments across all five Finnish university hospitals, as well as patient representatives from the Finnish Epilepsy Association, was established. The resulting pathway was adopted into the Finnish evidence-based current care guidelines for epilepsy.

The Finnish epilepsy care pathway focuses on timely referrals, continuity of care and enhanced communication between healthcare providers at different levels of care. Patient involvement is assured with an individualised digital application offering secure online messaging, a seizure calendar and remote visits. The pathway enhances virtual consultations and includes regular national diagnostic multidisciplinary meetings for severe epilepsies before selected cases are consulted in ERN EpiCARE meetings.

Publication:

Kälviäinen R, Hadj-Allal Z, Kirjavainen J, Roivainen R, Linnankivi T, Peltola J, et al. Epilepsy care pathway: The Finnish model. Epilepsia Open. 2024; 00: 1–9. https://doi.org/10.1002/epi4.13093

Kälviäinen R, Hadj-Allal Z, Kirjavainen J, Roivainen R, Linnankivi T, Peltola J, et al. Epilepsy care pathway: The Finnish model. Epilepsia Open. 2024; 00: 1–9. https://doi.org/10.1002/epi4.13093
Regions: Europe, Finland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2024 by DNN Corp Terms Of Use Privacy Statement